*MAG009* 1/25/2023 9:43:50 AM MAG009
State of Arkansas 1
94th General Assembly 2
Regular Session, 2023 SCR 3 3
4
By: Senator F. Love 5
By: Representative T. Shephard 6
7
SENATE CONCURRENT RESOLUTION 8
DESIGNATING HYPERTRO PHIC CARDIOMYOPATHY AWARENESS DAY 9
TO EDUCATE PEOPLE AB OUT HYPERTROPHIC CAR DIOMYOPATHY. 10
11
12
Subtitle 13
DESIGNATING HYPERTROPHIC CARDIOMYOPATHY 14
AWARENESS DAY TO EDUCATE PEOPLE ABOUT 15
HYPERTROPHIC CARDIOMYOPATHY. 16
17
18
BE IT RESOLVED BY THE SENATE OF THE NINETY -FOURTH GENERAL ASSEMBLY OF THE 19
STATE OF ARKANSAS, THE HOUSE OF REPRESENTATIVES CONCURRING THEREIN: 20
21
WHEREAS, Hypertrophic Cardiomyopathy (“HCM”) is a chronic 22
cardiovascular disease involving thickening of the heart m uscle and can 23
potentially lead to debilitating symptoms and serious complications including 24
heart failure, atrial fibrillation, stroke, and in rare cases sudden cardiac 25
death; and 26
27
WHEREAS, HCM is the most common inheritable heart disease and can 28
affect anyone regardless of age, gender, or ethnicity with a reported 29
prevalence ranging from one (1) in two hundred (200) to one (1) in five 30
hundred (500) in the general population; and 31
32
WHEREAS, an estimated seven hundred thousand (700,000) people in the 33
United States have HCM, yet eighty -five percent (85%) of them may remain 34
undiagnosed; and 35
36 SCR3
2 1/25/2023 9:43:50 AM MAG009
WHEREAS, HCM shares symptoms with other common cardiovascular and 1
pulmonary diseases, such as shortness of breath, chest pain, fatigue, 2
palpitations, and fainting, makin g it difficult to distinguish HCM from these 3
other diseases; and 4
5
WHEREAS, all-cause mortality risk is three (3) to four (4) times higher 6
in patients with HCM than that of the general population; and 7
8
WHEREAS, knowing one’s medical history and any si gns and symptoms of 9
HCM is an important first step in receiving an accurate diagnosis of HCM; and 10
11
WHEREAS, a healthcare provider must conduct a thorough screening with 12
cardiac health questions to help identify a risk of cardiac disorders both 13
genetic and congenital; and 14
15
WHEREAS, a healthcare provider may conduct several tests, including an 16
echocardiogram, a cardiac magnetic resonance image, or genetic testing to 17
confirm a family history of HCM, and must examine the heart to diagnose HCM; 18
and 19
20
WHEREAS, following a diagnosis of HCM, it is important for patients to 21
work with their healthcare provider to learn more about their disease and 22
understand different management options, including prescription medicines and 23
surgical treatment options that may help ; and 24
25
WHEREAS, the fourth Wednesday in February is an appropriate day to 26
observe Hypertrophic Cardiomyopathy Awareness Day, 27
28
NOW THEREFORE, 29
BE IT RESOLVED, BY THE SENATE OF THE NINETY -FOURTH GENERAL ASSEMBLY, THE 30
HOUSE OF REPRESENTATIVES CONCURRING THER EIN; 31
32
THAT the General Assembly: 33
(1) Recognize and designate the fourth Wednesday in February of 34
each year as “Hypertrophic Cardiomyopathy Awareness Day” in the State of 35
Arkansas in order to raise public awareness about hypertrophic 36 SCR3
3 1/25/2023 9:43:50 AM MAG009
cardiomyopathy; 1
(2) Acknowledge the critical importance of hypertrophic 2
cardiomyopathy awareness to improve cardiovascular health in the State of 3
Arkansas; 4
(3) Support raising awareness of the consequences of undiagnosed 5
and untreated hypertrophic cardiomyopathy and the need to seek appropriate 6
care for hypertrophic cardiomyopathy as a serious public health issue; and 7
(4) Respectfully request the Governor to annually issue a 8
proclamation recognizing the fourth Wednesday in February in the State of 9
Arkansas as “Hypertrophic Cardiomyopathy Awareness Day” and call upon the 10
people in the State of Arkansas to observe the day with appropriate programs 11
and activities. 12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36